Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 409,595 |
|
|||||
| News | - | ||||||
| Day High | 0.46 | Low High |
|||||
| Day Low | 0.3951 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| OpGen Inc | OPGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0299 | 7.47% | 0.43 | 17:20:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.40 | 0.3951 | 0.46 | 0.437899 | 0.4001 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 799 | 409,595 | US$ 0.4243796 | US$ 173,824 | - | 0.165 - 9.054 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:20:16 | formt | 2,815 | US$ 0.43 | USD |
OpGen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.41M | 10.01M | - | 2.61M | -37.28M | -3.72 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OpGen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/23/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 11/14/2023 | 15:30 | GlobeNewswire Inc. | OpGen Reports Third Quarter 2023 Financial Results and.. |
| 11/13/2023 | 15:59 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 11/07/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/26/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/16/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/13/2023 | 16:18 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 10/13/2023 | 16:17 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 10/13/2023 | 16:15 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 10/13/2023 | 16:14 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 10/13/2023 | 16:13 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 10/12/2023 | 11:32 | GlobeNewswire Inc. | OpGen Enters Into Warrant Inducement Transaction for up to.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OPGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.455 | 0.4879 | 0.3951 | 0.4297342 | 157,563 | -0.025 | -5.49% |
| 1 Month | 0.74 | 0.7998 | 0.3951 | 0.5379589 | 312,076 | -0.31 | -41.89% |
| 3 Months | 0.1995 | 3.84 | 0.19 | 0.6874312 | 4,795,767 | 0.2305 | 115.54% |
| 6 Months | 0.7002 | 3.84 | 0.165 | 0.659118 | 2,455,969 | -0.2702 | -38.59% |
| 1 Year | 3.196 | 9.054 | 0.165 | 2.39 | 2,626,431 | -2.77 | -86.55% |
| 3 Years | 39.00 | 87.40 | 0.165 | 32.73 | 2,362,540 | -38.57 | -98.9% |
| 5 Years | 22.00 | 256.00 | 0.165 | 39.68 | 2,063,447 | -21.57 | -98.05% |
OpGen Description
| OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base. |
